These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11480457)

  • 21. Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats.
    Santuré M; Pitre M; Nadeau A; Bachelard H
    Metabolism; 2003 Aug; 52(8):978-86. PubMed ID: 12898461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.
    Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H
    J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of troglitazone on leptin production. Studies in vitro and in human subjects.
    Nolan JJ; Olefsky JM; Nyce MR; Considine RV; Caro JF
    Diabetes; 1996 Sep; 45(9):1276-8. PubMed ID: 8772734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
    Kitakoshi K; Oshida Y; Nakai N; Han YQ; Sato Y
    Horm Metab Res; 2001 Jun; 33(6):365-9. PubMed ID: 11456287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial.
    Nakamura T; Funahashi T; Yamashita S; Nishida M; Nishida Y; Takahashi M; Hotta K; Kuriyama H; Kihara S; Ohuchi N; Nishimura T; Kishino BI; Ishikawa K; Kawamoto T; Tokunaga K; Nakagawa C; Mineo I; Watanabe F; Tarui S; Matsuzawa Y
    Diabetes Res Clin Pract; 2001 Dec; 54(3):181-90. PubMed ID: 11689273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pioglitazone-induced insulin sensitization improves vascular endothelial function in nondiabetic patients with essential hypertension.
    Horio T; Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Yoshimasa Y; Kawano Y
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1626-30. PubMed ID: 16364837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus.
    Sung BH; Izzo JL; Dandona P; Wilson MF
    Hypertension; 1999 Jul; 34(1):83-8. PubMed ID: 10406828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.
    O'Rourke CM; Davis JA; Saltiel AR; Cornicelli JA
    Metabolism; 1997 Feb; 46(2):192-8. PubMed ID: 9030828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes.
    Levin K; Hother-Nielsen O; Henriksen JE; Beck-Nielsen H
    Diabetes Care; 2004 Jan; 27(1):148-54. PubMed ID: 14693981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of high-dose troglitaz one on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits.
    Zhang B; Shiomi M; Tanaka H; Mei J; Fan P; Tsujita Y; Horikoshi H; Saku K
    Eur J Drug Metab Pharmacokinet; 2001; 26(3):185-92. PubMed ID: 11695719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus.
    Prigeon RL; Kahn SE; Porte D
    J Clin Endocrinol Metab; 1998 Mar; 83(3):819-23. PubMed ID: 9506734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.
    Antonucci T; Whitcomb R; McLain R; Lockwood D; Norris RM
    Diabetes Care; 1997 Feb; 20(2):188-93. PubMed ID: 9118772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of troglitazone on blood insulin levels after pancreas transplantation with systemic venous drainage in rats.
    Uchiyama K; Nakai I; Shimizu Y; Mitsuo M; Yasunami Y; Oka T
    Transplantation; 1997 Nov; 64(10):1476-8. PubMed ID: 9392315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects.
    Gabriely I; Wozniak R; Hawkins M; Shamoon H
    J Clin Endocrinol Metab; 2001 Feb; 86(2):521-8. PubMed ID: 11158003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD; Campbell LK; Campbell RK
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus.
    Shimizu K; Shiratori K; Hayashi N; Fujiwara T; Horikoshi H
    Pancreas; 2000 Nov; 21(4):421-6. PubMed ID: 11075998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro.
    Gralinski MR; Rowse PE; Breider MA
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):909-13. PubMed ID: 9641476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Troglitazone corrects metabolic changes but not vascular dysfunction in dietary-obese rats.
    Naderali EK; Pickavance LC; Wilding JP; Doyle PJ; Williams G
    Eur J Pharmacol; 2001 Mar; 416(1-2):133-9. PubMed ID: 11282122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats.
    Yoshino K; Takeda N; Sugimoto M; Nakashima K; Okumura S; Hattori J; Sasaki A; Kawachi S; Takami K; Takami R; Yasuda K
    Metabolism; 1999 Nov; 48(11):1418-23. PubMed ID: 10582551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.